Comparison of two basal insulin analogs (insulin lispro protamine suspension and insulin determir) in basal-bolus therapy for patients with type 1 diabetes.

Trial Profile

Comparison of two basal insulin analogs (insulin lispro protamine suspension and insulin determir) in basal-bolus therapy for patients with type 1 diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs Insulin detemir; Insulin neutral protamine lispro/insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 25 Sep 2008 The actual number of patients enrolled was 388 according to ClinicalTrials.gov record.
    • 25 Sep 2008 Status changed from active, no longer recruiting to completed as reported in the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top